A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

Pomalidomide reverses  -globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors

(2015) B. M. Dulmovits et al.   BLOOD

Efficacy of ruxolitinib for myelofibrosis

(2014) Fabio PS Santos et al.   EXPERT OPINION ON PHARMACOTHERAPY

Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib

(2014) Mirela Andrei et al.   LEUKEMIA & LYMPHOMA

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management

(2013) Ayalew Tefferi   AMERICAN JOURNAL OF HEMATOLOGY

Pomalidomide

(2013) M. Q. Lacy et al.   BLOOD

Pomalidomide: First Global Approval

(2013) Shelley Elkinson et al.   DRUGS

RBC-transfusion guidelines update

(2012) R.P. Gale et al.   LEUKEMIA RESEARCH

International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens

(2010) Prakash Thapaliya et al.   AMERICAN JOURNAL OF HEMATOLOGY

Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS

(2010) C. Elena et al.   HAEMATOLOGICA

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

(2010) Naseema Gangat et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase-2 trial of low-dose pomalidomide in myelofibrosis

(2010) K H Begna et al.   LEUKEMIA

MPN-associated myelofibrosis (MPN-MF)

(2010) R.A. Mesa et al.   LEUKEMIA RESEARCH

What are RBC-transfusion-dependence and -independence?

(2010) R.P. Gale et al.   LEUKEMIA RESEARCH

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not

(2009) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis

(2009) Alfonso Quintás-Cardama et al.   JOURNAL OF CLINICAL ONCOLOGY

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

(2009) Ayalew Tefferi et al.   JOURNAL OF CLINICAL ONCOLOGY

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD

Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells

(2008) Laure A. Moutouh-de Parseval et al.   JOURNAL OF CLINICAL INVESTIGATION